RE:RE:RE:Crazy valuations in the stem cell space-$8 billlion company Agreed. I think first they need to close financing, do the reverse and also list in USA properly. There is a massive amount of work to do here. The CEO will make it move forward with some help as well. Then you do Frankfurt. Agreed. Biotech is more interesting in USA though i think but one does not prevent the other.
Pimpovish wrote: Auric, I'm surprised the company does not have a Frankfurt listing. It's a very simple and low cost procedure. German investors would love this story.